BioSpace News Archive

Today, Two Labs, an Envision Pharma Company and industry leader in pharma services, officially launched its Sunshine Transparency and Aggregate Spend service.

Sensei Biotherapeutics, Inc. today announced that Company management will present at the following conferences in February 2024: Oppenheimer’s 34th Annual Healthcare Life Sciences Conference Wednesday, February 14, 2024, at 10:00 a.m. ET.

Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its fourth quarter 2023 financial results on Wednesday, February 21, 2024.

Anavex Life Sciences Corp. today reported financial results for its fiscal quarter ended December 31, 2023.

PepGen Inc. today announced the pricing of an underwritten offering of 7,530,000 shares of its common stock at a price to the public of $10.635 per share.

- BridgeBio grants Kyowa Kirin exclusive license to develop and commercialize infigratinib for skeletal dysplasias in Japan.

Volta Labs and Element Biosciences, Inc. today announced a collaboration to optimize sequencing throughput with the launch of Volta’s Callisto™ Sample Prep System for Element’s AVITI.

Coeptis Therapeutics Holdings, Inc. today announced plans to pursue DVX201, its proprietary allogeneic stem cell expansion and directed differentiation platform of unmodified natural killer (NK) cell therapy, as an antiviral treatment addressing various respiratory viral infections that lead to hospitalization, including the “tripledemic” of influenza, COVID-19 and respiratory syncytial virus (RSV).

Hygiene and health company Essity has, for the third consecutive year, been included in S&P Global’s Sustainability Yearbook.

Teva Canada Named by Forbes as No. 1 Canadian Employer in Drugs & Biotechnology Industry.